Profile | GDS5420 / 1557195_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 166.93 | 49 |
GSM1296119 | B_lesional_pre-dose | 405.15 | 64 |
GSM1296076 | C_lesional_pre-dose | 210.27 | 55 |
GSM1296092 | D_lesional_pre-dose | 249.28 | 58 |
GSM1296103 | E_lesional_pre-dose | 106.57 | 43 |
GSM1296078 | F_lesional_pre-dose | 229.26 | 56 |
GSM1296107 | G_lesional_pre-dose | 263.35 | 57 |
GSM1296109 | H_lesional_pre-dose | 216.6 | 52 |
GSM1296080 | I_lesional_pre-dose | 481.86 | 67 |
GSM1296090 | J_lesional_pre-dose | 283.43 | 59 |
GSM1296074 | K_lesional_pre-dose | 141.06 | 49 |
GSM1296111 | L_lesional_pre-dose | 263.39 | 56 |
GSM1296099 | M_lesional_pre-dose | 178.9 | 50 |
GSM1296086 | O_lesional_pre-dose | 183.54 | 52 |
GSM1296117 | P_lesional_pre-dose | 180.63 | 49 |
GSM1296113 | Q_lesional_pre-dose | 430.49 | 65 |
GSM1296096 | R_lesional_pre-dose | 140.51 | 47 |
GSM1296105 | S_lesional_pre-dose | 576.81 | 70 |
GSM1296098 | T_lesional_pre-dose | 158.48 | 48 |
GSM1296101 | U_lesional_pre-dose | 306.88 | 59 |
GSM1296121 | V_lesional_pre-dose | 237.97 | 55 |
GSM1296088 | W_lesional_pre-dose | 361.65 | 62 |
GSM1296082 | X_lesional_pre-dose | 132.84 | 48 |
GSM1296115 | Y_lesional_pre-dose | 182.8 | 50 |
GSM1296084 | Z_lesional_pre-dose | 264.58 | 57 |
GSM1296072 | B_lesional_day8 | 649.32 | 72 |
GSM1296069 | L_lesional_day8 | 220.08 | 52 |
GSM1296071 | P_lesional_day8 | 503.6 | 67 |
GSM1296070 | Y_lesional_day8 | 363.43 | 61 |
GSM1296073 | V_lesional_day8 | 190.11 | 52 |
GSM1296034 | A_lesional_day15 | 726.93 | 73 |
GSM1296041 | G_lesional_day15 | 216.7 | 53 |
GSM1296035 | R_lesional_day15 | 146.09 | 48 |
GSM1296038 | U_lesional_day15 | 137.83 | 46 |
GSM1296047 | B_lesional_day15 | 602.89 | 71 |
GSM1296039 | E_lesional_day15 | 145.67 | 48 |
GSM1296042 | H_lesional_day15 | 516.01 | 68 |
GSM1296043 | L_lesional_day15 | 257.75 | 55 |
GSM1296037 | M_lesional_day15 | 411.4 | 64 |
GSM1296046 | P_lesional_day15 | 480.85 | 67 |
GSM1296044 | Q_lesional_day15 | 443.95 | 65 |
GSM1296045 | Y_lesional_day15 | 525.59 | 68 |
GSM1296025 | C_lesional_day15 | 943.23 | 78 |
GSM1296033 | D_lesional_day15 | 888.42 | 77 |
GSM1296027 | I_lesional_day15 | 1824.67 | 87 |
GSM1296032 | J_lesional_day15 | 927.26 | 78 |
GSM1296024 | K_lesional_day15 | 973.78 | 78 |
GSM1296031 | W_lesional_day15 | 541.32 | 69 |
GSM1296028 | X_lesional_day15 | 789.91 | 75 |
GSM1296029 | Z_lesional_day15 | 584.43 | 70 |
GSM1296026 | F_lesional_day15 | 534.78 | 69 |
GSM1296030 | O_lesional_day15 | 627.2 | 71 |
GSM1296040 | S_lesional_day15 | 250.01 | 56 |
GSM1296036 | T_lesional_day15 | 250.32 | 55 |
GSM1296048 | V_lesional_day15 | 305.64 | 59 |
GSM1296059 | A_lesional_day43 | 186.98 | 52 |
GSM1296066 | G_lesional_day43 | 247.68 | 55 |
GSM1296060 | R_lesional_day43 | 358.75 | 62 |
GSM1296063 | U_lesional_day43 | 255.76 | 56 |
GSM1296064 | E_lesional_day43 | 137.88 | 47 |
GSM1296067 | H_lesional_day43 | 548.82 | 69 |
GSM1296062 | M_lesional_day43 | 270.94 | 57 |
GSM1296068 | Q_lesional_day43 | 584.79 | 70 |
GSM1296050 | C_lesional_day43 | 701.09 | 73 |
GSM1296057 | D_lesional_day43 | 988.45 | 79 |
GSM1296052 | I_lesional_day43 | 1711.82 | 87 |
GSM1296054 | J_lesional_day43 | 916.82 | 78 |
GSM1296049 | K_lesional_day43 | 755.56 | 74 |
GSM1296055 | W_lesional_day43 | 332.52 | 60 |
GSM1296053 | X_lesional_day43 | 976.34 | 79 |
GSM1296058 | Z_lesional_day43 | 308.86 | 60 |
GSM1296051 | F_lesional_day43 | 309.07 | 61 |
GSM1296056 | O_lesional_day43 | 209.15 | 54 |
GSM1296065 | S_lesional_day43 | 623.85 | 71 |
GSM1296061 | T_lesional_day43 | 308.16 | 59 |
GSM1296095 | A_non-lesional_pre-dose | 147.77 | 48 |
GSM1296120 | B_non-lesional_pre-dose | 492.19 | 67 |
GSM1296077 | C_non-lesional_pre-dose | 619.51 | 71 |
GSM1296093 | D_non-lesional_pre-dose | 923.51 | 78 |
GSM1296104 | E_non-lesional_pre-dose | 227.03 | 54 |
GSM1296079 | F_non-lesional_pre-dose | 610.16 | 71 |
GSM1296108 | G_non-lesional_pre-dose | 359.55 | 62 |
GSM1296110 | H_non-lesional_pre-dose | 489.18 | 67 |
GSM1296081 | I_non-lesional_pre-dose | 1005.14 | 79 |
GSM1296091 | J_non-lesional_pre-dose | 449.64 | 66 |
GSM1296075 | K_non-lesional_pre-dose | 383.07 | 64 |
GSM1296112 | L_non-lesional_pre-dose | 459.8 | 66 |
GSM1296100 | M_non-lesional_pre-dose | 464.16 | 66 |
GSM1296087 | O_non-lesional_pre-dose | 1285.03 | 82 |
GSM1296118 | P_non-lesional_pre-dose | 500.83 | 67 |
GSM1296114 | Q_non-lesional_pre-dose | 662.52 | 72 |
GSM1296097 | R_non-lesional_pre-dose | 301.61 | 59 |
GSM1296106 | S_non-lesional_pre-dose | 599.16 | 70 |
GSM1296102 | U_non-lesional_pre-dose | 568.95 | 69 |
GSM1296122 | V_non-lesional_pre-dose | 552.1 | 69 |
GSM1296089 | W_non-lesional_pre-dose | 559.85 | 69 |
GSM1296083 | X_non-lesional_pre-dose | 807.25 | 75 |
GSM1296116 | Y_non-lesional_pre-dose | 386.85 | 62 |
GSM1296085 | Z_non-lesional_pre-dose | 1077 | 80 |